Recall Register

Drug recall: Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of…

Class II FDA enforcement event 66124. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Pfizer Us Pharmaceutical Group started this drug recall on 4 Sep 2013. The firm address in the FDA record is in New York, NY. FDA put the recall in Class II. FDA event 66124 has 1 product record. The first FDA enforcement report date is 27 Nov 2013. The record gives the status Terminated, with the termination date 13 Apr 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Nationwide

Recalling firm

Pfizer Us Pharmaceutical Group, New York, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 66124: product records
Recall numberProductQuantityClassStatusReport date
D-014-2014Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfizer Inc, NY, NY 10017, NDC 0025-1031-3131 bottlesClass IITerminated27 Nov 2013

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2013
370
Share of these events in Class II
56%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
4

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 66124. https://recallregister.com/fda/ii/66124/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Nationwide
What quantity of product is in FDA event 66124?
The FDA record gives this quantity: 31 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2013 have the same class?
56% of the 370 drug events that started in 2013 are in Class II.